Evidence map›Paper›PMID 36976969›Full record

ArticleToxics2023

Identification of Real-Life Mixtures Using Human Biomonitoring Data: A Proof of Concept Study.

Laura Rodriguez Martin, Ilse Ottenbros, Nina Vogel, Marike Kolossa-Gehring, Phillipp Schmidt, Katarína Řiháčková, Miguel Juliá Molina, Elena Varea-Jiménez, Eva Govarts, Susana Pedraza-Diaz and 3 more

Abstract read
In one paragraph

Article in Toxics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Laura Rodriguez MartinHealth, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium.ORCID 0000-0001-6630-411X
Ilse OttenbrosInstitute for Risk Assessment Sciences (IRAS), Utrecht University, 3584 CM Utrecht, The Netherlands.ORCID 0000-0002-4854-3712
Nina VogelGerman Environment Agency (UBA), 14195 Berlin, Germany.ORCID 0000-0003-0295-9277
Marike Kolossa-GehringGerman Environment Agency (UBA), 14195 Berlin, Germany.ORCID 0000-0001-8644-7564
Phillipp SchmidtGerman Environment Agency (UBA), 14195 Berlin, Germany.
Katarína ŘiháčkováRECETOX, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic.ORCID 0000-0003-0222-801X
Miguel Juliá MolinaNational Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.
Elena Varea-JiménezNational Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.ORCID 0000-0001-9350-1178
Eva GovartsHealth, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium.
Susana Pedraza-DiazNational Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.ORCID 0000-0001-9401-6473
Erik LebretInstitute for Risk Assessment Sciences (IRAS), Utrecht University, 3584 CM Utrecht, The Netherlands.
Jelle VlaanderenInstitute for Risk Assessment Sciences (IRAS), Utrecht University, 3584 CM Utrecht, The Netherlands.
Mirjam LuijtenCentre for Health Protection, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.ORCID 0000-0002-5277-1443

Funding

CETOCOEN PLUS project CZ.02.1.01/0.0/0.0/15_003/0000469European Union's Horizon 2020 research and innovation program 733032European Union's Horizon 2020 research and innovation program 857560German Ministry for the Environment, Nature Conservation, Nuclear Safety and Consumer Protection German Ministry for the Environment, Nature Conservation, Nuclear Safety and Consumer ProtectionInstituto de Salud Carlos III (ISCIII) SEG 1251/07; SEG 1210/10Ministry of Education, Youth and Sports No LM2018121MONA (Mols Overleg Nucleair Afval) MONA (Mols Overleg Nucleair Afval)NIRAS/ONDRAF (Belgian National Agency for Radioactive Waste and enriched Fissile Material NIRAS/ONDRAF (Belgian National Agency for Radioactive Waste and enriched Fissile MaterialOP RDE-project CETOCOEN EXCELLENCE CZ.02.1.01/0.0/0.0/17_043/0009632Spanish Ministry of Agriculture, Food and Environment Spanish Ministry of Agriculture, Food and EnvironmentSTORA (Study and Consultation Radioactive Waste Dessel) STORA (Study and Consultation Radioactive Waste Dessel)
6 · The paper itself

Abstract

Human health risk assessment of chemical mixtures is complex due to the almost infinite number of possible combinations of chemicals to which people are exposed to on a daily basis. Human biomonitoring (HBM) approaches can provide inter alia information on the chemicals that are in our body at one point in time. Network analysis applied to such data may provide insight into real-life mixtures by visualizing chemical exposure patterns. The identification of groups of more densely correlated biomarkers, so-called "communities", within these networks highlights which combination of substances should be considered in terms of real-life mixtures to which a population is exposed. We applied network analyses to HBM datasets from Belgium, Czech Republic, Germany, and Spain, with the aim to explore its added value for exposure and risk assessment. The datasets varied in study population, study design, and chemicals analysed. Sensitivity analysis was performed to address the influence of different approaches to standardise for creatinine content of urine. Our approach demonstrates that network analysis applied to HBM data of highly varying origin provides useful information with regards to the existence of groups of biomarkers that are densely correlated. This information is relevant for regulatory risk assessment, as well as for the design of relevant mixture exposure experiments.

Indexed as

chemical mixturesclusteringcombined exposureHBM4EUhuman biomonitoringmixture risk assessmentnetwork analysis

Identifiers

PMID36976969
PMCPMC10058482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.